Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vrajesh V Parekh

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Immunotherapy|December 23, 2010
Invariant NK T cells: potential for immunotherapeutic targeting with glycolipid antigensLuc Van Kaer, Vrajesh V Parekh, Lan Wu
Cell and Tissue Research|August 25, 2010
Invariant natural killer T cells: bridging innate and adaptive immunityLuc Van Kaer, Vrajesh V Parekh, Lan Wu
Frontiers in Immunology|June 2, 2015
The Response of CD1d-Restricted Invariant NKT Cells to Microbial Pathogens and Their ProductsLuc Van Kaer, Vrajesh V Parekh, Lan Wu
International Reviews of Immunology|April 25, 2007
The in vivo response of invariant natural killer T cells to glycolipid antigensVrajesh V Parekh, Saif Lalani, Luc Van Kaer
Trends in Immunology|September 29, 2012
Invariant natural killer T cells as sensors and managers of inflammationLuc Van Kaer, Vrajesh V Parekh, Lan Wu
Immunology|June 3, 2015
Natural killer T cells in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitisLuc Van Kaer, Lan Wu, Vrajesh V Parekh
Critical Reviews in Immunology|July 29, 2005
iNKT-cell responses to glycolipidsVrajesh V Parekh, Michael T Wilson, Luc Van Kaer
Molecular Immunology|November 12, 2017
Role of autophagy in MHC class I-restricted antigen presentationLuc Van Kaer, Vrajesh V Parekh, J Luke Postoak, et al.
Expert Review of Vaccines|December 5, 2008
Glycolipid ligands of invariant natural killer T cells as vaccine adjuvantsSungjune Kim, Saif Lalani, Vrajesh V Parekh, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 15, 2014
Spleen supports a pool of innate-like B cells in white adipose tissue that protects against obesity-associated insulin resistanceLan Wu, Vrajesh V Parekh, Joseph Hsiao, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Immunotherapy|December 23, 2010
Invariant NK T cells: potential for immunotherapeutic targeting with glycolipid antigensLuc Van Kaer, Vrajesh V Parekh, Lan Wu
Cell and Tissue Research|August 25, 2010
Invariant natural killer T cells: bridging innate and adaptive immunityLuc Van Kaer, Vrajesh V Parekh, Lan Wu
Frontiers in Immunology|June 2, 2015
The Response of CD1d-Restricted Invariant NKT Cells to Microbial Pathogens and Their ProductsLuc Van Kaer, Vrajesh V Parekh, Lan Wu
International Reviews of Immunology|April 25, 2007
The in vivo response of invariant natural killer T cells to glycolipid antigensVrajesh V Parekh, Saif Lalani, Luc Van Kaer
Trends in Immunology|September 29, 2012
Invariant natural killer T cells as sensors and managers of inflammationLuc Van Kaer, Vrajesh V Parekh, Lan Wu
Immunology|June 3, 2015
Natural killer T cells in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitisLuc Van Kaer, Lan Wu, Vrajesh V Parekh
Critical Reviews in Immunology|July 29, 2005
iNKT-cell responses to glycolipidsVrajesh V Parekh, Michael T Wilson, Luc Van Kaer
Molecular Immunology|November 12, 2017
Role of autophagy in MHC class I-restricted antigen presentationLuc Van Kaer, Vrajesh V Parekh, J Luke Postoak, et al.
Expert Review of Vaccines|December 5, 2008
Glycolipid ligands of invariant natural killer T cells as vaccine adjuvantsSungjune Kim, Saif Lalani, Vrajesh V Parekh, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 15, 2014
Spleen supports a pool of innate-like B cells in white adipose tissue that protects against obesity-associated insulin resistanceLan Wu, Vrajesh V Parekh, Joseph Hsiao, et al.
Pageof 4